Digital pathology is a digital version of conventional pathological tests and labs. The digitalization facilitates better workflow efficiency, accurate analyses with minimal of error rate. A single digital pathological test instrument operated by a single pathologist can accomplish tests that were formerly done using five conventional pathological instruments.
The digital pathology systems are getting very popular worldwide attributed mainly to its capability to efficiently recognize and validate new drug candidates, create molecular treatments and measure toxicology in the new drug and classify patients for the treatment. Whole slide imaging (WSI) is the most widely adopted technology for the digital pathology attributed to its advantages such as Z-axis scanning of the slides, enhanced regulation of the digital images in shorter time span, and multiple magnification. The increasing use of digital pathology in academics due to dynamic telepathology and real time imaging and controlled movement, are expected to drive the digital pathology market in coming years.
Explore more about “global digital pathology market” at: https://www.psmarketresearch.com/market-analysis/digital-pathology-market
Based on the various products the global digital pathology market can be broadly classified as scanners, analytics, storage and communication or delivery modes. Based on the different application of digital pathology the global digital pathology market can be segmented as human pathology (including Pharmaceutical & Biotechnology Companies, Training and Education and others), animal pathology (including pharmaceutical & biotechnology companies, academic & government research institutes, and contract research organizations).
The major driver for the growth of the digital pathology market includes worldwide growth in the prevalence of cancer, and cumulative use of companion diagnostics in chronic diseases. Some of the other important drivers for the digital pathology market include the growing efficiency of the medical lab, and increasing clinical trials and drug development activities around the globe.
Some of the major players operating in the global digital pathology market include, 3dhistech Ltd., Aurora Interactive Ltd., Definiens AG, Hamamatsu Photonics K.K., Indica Labs, Inc., Leica Biosystems, Gmbh, Mikroscan Technologies, Inc., Objective Pathology Services, Ltd., Xifin, Inc., Pixcelldata, Ltd., Ventana Medical Systems, Inc., Apollo Pacs, Inc., Corista LLC, Digipath, Inc., Huron Technologies International, Inc., Kanteron Systems, Ligolab, LLC , Nikon Instruments, Inc., Omnyx, LLC, Pathxl, Ltd., Sunquest Information Systems, Inc., and Visiopharm.
Browse Other Related Report at: https://www.psmarketresearch.com/industry-report/medical-devices